Imagin Medical (Imagin Medical) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Imagin Medical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Imagin Medical's annualized Gross Profit for the quarter that ended in Mar. 2023 was $0.00 Mil. Imagin Medical's average Total Assets over the quarter that ended in Mar. 2023 was $0.86 Mil. Therefore, Imagin Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 was 0.00%.

Imagin Medical Gross-Profit-to-Asset % Historical Data

The historical data trend for Imagin Medical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imagin Medical Gross-Profit-to-Asset % Chart

Imagin Medical Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

Imagin Medical Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Imagin Medical's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Imagin Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imagin Medical's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Imagin Medical's Gross-Profit-to-Asset % falls into.

Imagin Medical Gross-Profit-to-Asset % Calculation

Imagin Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2022 )	/	( (Total Assets (A: Sep. 2021 )	+	Total Assets (A: Sep. 2022 ))	/ count )
	=	0	/	( (0.612	+	1.013)	/ 2 )
	=	0	/	0.8125
	=	0.00 %

Imagin Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
	=	0	/	( (0.883	+	0.835)	/ 2 )
	=	0	/	0.859
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Imagin Medical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Imagin Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Imagin Medical (Imagin Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imagin Medical Inc (OTCPK:IMEXF) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

DPD3:Germany IME:Canada

Address

890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9

Website

https://www.imaginmedical.com

Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.